Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals Inc (ENTA) Implied Volatility Current
ENTA implied volatility is 121%. IV Rank is 88%, placing current premiums in the top of their 52-week range.
Read more
Tracking ENTA implied volatility helps you identify when options premiums on Enanta Pharmaceuticals Inc are historically cheap or expensive, and where the best trades are hiding. Enanta Pharmaceuticals Inc implied volatility reflects the market's expectation of future price movement: when ENTA IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Enanta Pharmaceuticals Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ENTA, tracking metrics like ENTA IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ENTA signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ENTA implied volatility sits today versus where it has been. Our scanner ranks Enanta Pharmaceuticals Inc implied volatility against its historical range, surfaces extremes in ENTA IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Enanta Pharmaceuticals Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is near its yearly peak - premiums are expensive, favoring sellers.
As of September 17, 2026
Trade options with IV on your side
Track ENTA IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→